BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 10049356)

  • 1. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis.
    Grumont RJ; Rourke IJ; Gerondakis S
    Genes Dev; 1999 Feb; 13(4):400-11. PubMed ID: 10049356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis.
    Zong WX; Edelstein LC; Chen C; Bash J; Gélinas C
    Genes Dev; 1999 Feb; 13(4):382-7. PubMed ID: 10049353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells.
    Grumont RJ; Rourke IJ; O'Reilly LA; Strasser A; Miyake K; Sha W; Gerondakis S
    J Exp Med; 1998 Mar; 187(5):663-74. PubMed ID: 9480976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance of nuclear factor-kappa B/Rel and c-myc expression during CD40 ligand rescue of WEHI 231 early B cells from receptor-mediated apoptosis through modulation of I kappa B proteins.
    Schauer SL; Wang Z; Sonenshein GE; Rothstein TL
    J Immunol; 1996 Jul; 157(1):81-6. PubMed ID: 8683159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: modulation of interferon-regulated gene expression by rel/nuclear factor kappaB.
    Grumont RJ; Gerondakis S
    J Exp Med; 2000 Apr; 191(8):1281-92. PubMed ID: 10770796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NF-kappa B-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bfl-1/A1.
    Edelstein LC; Lagos L; Simmons M; Tirumalai H; Gélinas C
    Mol Cell Biol; 2003 Apr; 23(8):2749-61. PubMed ID: 12665576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line.
    Lee H; Arsura M; Wu M; Duyao M; Buckler AJ; Sonenshein GE
    J Exp Med; 1995 Mar; 181(3):1169-77. PubMed ID: 7869034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression.
    Grossmann M; O'Reilly LA; Gugasyan R; Strasser A; Adams JM; Gerondakis S
    EMBO J; 2000 Dec; 19(23):6351-60. PubMed ID: 11101508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways.
    Andjelic S; Hsia C; Suzuki H; Kadowaki T; Koyasu S; Liou HC
    J Immunol; 2000 Oct; 165(7):3860-7. PubMed ID: 11034392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors.
    Bash J; Zong WX; Banga S; Rivera A; Ballard DW; Ron Y; Gélinas C
    EMBO J; 1999 May; 18(10):2803-11. PubMed ID: 10329626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Participation of the E3-ligase TRIM13 in NF-κB p65 activation and NFAT-dependent activation of c-Rel upon T-cell receptor engagement.
    Hatchi EM; Poalas K; Cordeiro N; N'Debi M; Gavard J; Bidère N
    Int J Biochem Cell Biol; 2014 Sep; 54():217-22. PubMed ID: 25088585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis.
    Owyang AM; Tumang JR; Schram BR; Hsia CY; Behrens TW; Rothstein TL; Liou HC
    J Immunol; 2001 Nov; 167(9):4948-56. PubMed ID: 11673501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells.
    Venkataraman L; Burakoff SJ; Sen R
    J Exp Med; 1995 Mar; 181(3):1091-9. PubMed ID: 7532676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NFAT but not NF-kappaB is critical for transcriptional induction of the prosurvival gene A1 after IgE receptor activation in mast cells.
    Ullerås E; Karlberg M; Möller Westerberg C; Alfredsson J; Gerondakis S; Strasser A; Nilsson G
    Blood; 2008 Mar; 111(6):3081-9. PubMed ID: 18182578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6 rescues the hyporesponsiveness of c-Rel deficient B cells independent of Bcl-xL, Mcl-1, and Bcl-2.
    Tumang JR; Hsia CY; Tian W; Bromberg JF; Liou HC
    Cell Immunol; 2002; 217(1-2):47-57. PubMed ID: 12426000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappaB/p50 and NF-kappaB/c-Rel differentially regulate the activity of the 3'alphaE-hsl,2 enhancer in normal murine B cells in an activation-dependent manner.
    Zelazowski P; Shen Y; Snapper CM
    Int Immunol; 2000 Aug; 12(8):1167-72. PubMed ID: 10917891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death.
    Zheng Y; Ouaaz F; Bruzzo P; Singh V; Gerondakis S; Beg AA
    J Immunol; 2001 Apr; 166(8):4949-57. PubMed ID: 11290773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALT1 directs B cell receptor-induced canonical nuclear factor-kappaB signaling selectively to the c-Rel subunit.
    Ferch U; zum Büschenfelde CM; Gewies A; Wegener E; Rauser S; Peschel C; Krappmann D; Ruland J
    Nat Immunol; 2007 Sep; 8(9):984-91. PubMed ID: 17660823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression.
    Köntgen F; Grumont RJ; Strasser A; Metcalf D; Li R; Tarlinton D; Gerondakis S
    Genes Dev; 1995 Aug; 9(16):1965-77. PubMed ID: 7649478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the IL-21 gene by the NF-κB transcription factor c-Rel.
    Chen G; Hardy K; Bunting K; Daley S; Ma L; Shannon MF
    J Immunol; 2010 Aug; 185(4):2350-9. PubMed ID: 20639489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.